Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Pharmacokinetics
Published in: Clinical Pharmacokinetics 10/2014

01-10-2014 | Erratum

Erratum to: Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition

Authors: Zhe-Yi Hu, Andrea N. Edginton, S. Casey Laizure, Robert B. Parker

Published in: Clinical Pharmacokinetics | Issue 10/2014

Login to get access

Excerpt

A Published-Ahead-of-Print version of this article was made available online on 08 August 2014. Errors have subsequently been identified in that version of the article, and the following corrections should be noted: …
Metadata
Title
Erratum to: Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition
Authors
Zhe-Yi Hu
Andrea N. Edginton
S. Casey Laizure
Robert B. Parker
Publication date
01-10-2014
Publisher
Springer International Publishing
Published in
Clinical Pharmacokinetics / Issue 10/2014
Print ISSN: 0312-5963
Electronic ISSN: 1179-1926
DOI
https://doi.org/10.1007/s40262-014-0174-x

Other articles of this Issue 10/2014

Clinical Pharmacokinetics 10/2014 Go to the issue

Review Article

Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults

Commentary

Protein Engineering for Improved Pharmacologic Characteristics of Established Monoclonal Antibody-Based Therapeutics

Original Research Article

Population Pharmacokinetics of Rabeprazole and Dosing Recommendations for the Treatment of Gastroesophageal Reflux Disease in Children Aged 1–11 Years

Original Research Article

Midazolam Pharmacokinetics in Morbidly Obese Patients Following Semi-Simultaneous Oral and Intravenous Administration: A Comparison with Healthy Volunteers

Original Research Article

Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers: Integrated Analysis of Intravenous and Subcutaneous, Single- and Multiple-Dose Administration

Leading Article

Pharmacokinetic Enhancers in HIV Therapeutics